logo-loader
viewFinablr PLC

Finablr shares rally as JP Morgan and Barclays talk up Travelex owner

Finablr shares have fallen 24% since floating last month and its B2B payment technology business is being valued at around a 75% discount to the wider peer group, JP Morgan said

travelex
Finablr's three business lines include B2B payments and consumer currency exchange

Shares in Travelex owner Finablr PLC (LON:FIN) moved higher on Tuesday as JPMorgan Cazenove and Barclays began coverage of the UAE-based payments and bureau de change group. 

When it floated in May, Finablr was forced to slash the pricing of its offer to 174p per share from the initial 210p-260p range at a cut-price, and, not helped by a modest trading update for Travelex, has since seen its shares sink below 135p this month. 

READ: Travelex owner Finablr considers London float after strong demand for Network International IPO

But analysts at both banks saw value in the triple offer of B2B payment technology, consumer cross-border payments and bureau de change shops, with Cazenove setting a share price target of 190p and an ‘overweight’ rating, while Barclays set its target at 170p with an ‘equal weight’ rating. 

Cazenove, which was a sponsor on the IPO, said that Finablr’s payments and FX platform is underpinned by scalable proprietary technology that “provides a competitive advantage that would take a significant period to replicate” and offers the company the capacity to manage three times its current volumes. 

Caz estimates compound annual growth of underlying earnings (EBITDA) of 19% for the period from 2018 to 2021.

At the current share price, Finablr’s fast-growing B2B payment technology business is valued at around a 75% discount to the wider peer group, Cazenove said and the group's valuation “presents attractive risk-reward”.

Barclays calls for patience

Similarly Barclays, which was a joint co-ordinator on the IPO, sees lots to like from Finablr differentiating its offer from peers through its extensive pay-in and pay-out network, licences, technology and the strong consumer brands it owns, which has resulted in large tech businesses increasingly using its services. 

With the company guiding to high single-digit revenue growth with EBITDA margin approaching 20% over the medium term, implying high-teens EBITDA growth, Barclays valuation is based on a 12-time 2020 earnings per share “and implying fundamental valuation upside”. 

“However, we expect it will take time and a number of positive data points for the market to attribute fair value to the stock,” analysts added, with a likely second-half weighting and a continued lack of clarity around Brexit.

Finablr shares were up almost 3% to 145p on Tuesday morning.

Quick facts: Finablr PLC

Price: 214.2 GBX

LSE:FIN
Market: LSE
Market Cap: £15.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical sees 'potentially quicker route to market' for its erectile...

Futura Medical PLC's (LON:FUM) executive director and head of R&D Ken James speaks to Proactive London's Andrew Scott following the read-out from the phase III clinical trial of its erectile dysfunction gel. James says while MED2005 showed strong efficacy, excellent safety and rapid speed...

53 minutes ago

2 min read